K. I. Birkeland

1.2k total citations
19 papers, 823 citations indexed

About

K. I. Birkeland is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, K. I. Birkeland has authored 19 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in K. I. Birkeland's work include Diabetes Management and Research (7 papers), Diabetes Treatment and Management (6 papers) and Metabolism, Diabetes, and Cancer (3 papers). K. I. Birkeland is often cited by papers focused on Diabetes Management and Research (7 papers), Diabetes Treatment and Management (6 papers) and Metabolism, Diabetes, and Cancer (3 papers). K. I. Birkeland collaborates with scholars based in Norway, United States and United Kingdom. K. I. Birkeland's co-authors include Bente Kilhovd, Tore Julsrud Berg, Per Medbøe Thorsby, Peter A. Torjesen, K. F. Hanssen, Petter Urdal, Kristian F. Hanssen, Ingvar Hjermann, Sigmund A. Anderssen and Ingar Holme and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetologia.

In The Last Decade

K. I. Birkeland

19 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. I. Birkeland Norway	9	375	285	190	142	102	19	823
Kumiko Furuki Japan	11	225 0.6×	209 0.7×	177 0.9×	85 0.6×	99 1.0×	12	821
Bilgin Özmen Türkiye	15	253 0.7×	68 0.2×	95 0.5×	109 0.8×	134 1.3×	32	727
Gaëtan Prévost France	18	407 1.1×	147 0.5×	160 0.8×	59 0.4×	158 1.5×	68	1.1k
L. Kennedy United States	19	741 2.0×	175 0.6×	178 0.9×	47 0.3×	213 2.1×	48	1.3k
Zilin Sun China	18	306 0.8×	119 0.4×	311 1.6×	35 0.2×	185 1.8×	58	895
Thorbjørn Grøfte Denmark	18	314 0.8×	84 0.3×	245 1.3×	36 0.3×	131 1.3×	49	782
J. D. Lefrandt Netherlands	10	182 0.5×	99 0.3×	200 1.1×	40 0.3×	39 0.4×	17	815
Brad P. Dieter United States	14	173 0.5×	47 0.2×	148 0.8×	98 0.7×	159 1.6×	24	801
Emily Tsai United States	9	190 0.5×	90 0.3×	187 1.0×	23 0.2×	66 0.6×	10	570
Catherine Niewoehner United States	14	186 0.5×	48 0.2×	198 1.0×	189 1.3×	120 1.2×	25	758

Countries citing papers authored by K. I. Birkeland

Since Specialization

Citations

This map shows the geographic impact of K. I. Birkeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. I. Birkeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. I. Birkeland more than expected).

Fields of papers citing papers by K. I. Birkeland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. I. Birkeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. I. Birkeland. The network helps show where K. I. Birkeland may publish in the future.

Co-authorship network of co-authors of K. I. Birkeland

This figure shows the co-authorship network connecting the top 25 collaborators of K. I. Birkeland. A scholar is included among the top collaborators of K. I. Birkeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. I. Birkeland. K. I. Birkeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Lee, Sanghoon, Torgrim M. Langleite, Frode Norheim, et al.. (2014). Subsarcolemmal lipid droplet responses to exercise training. 1 indexed citations

Atkin, Stephen L., Steve Baín, S Gough, et al.. (2011). Insulin degludec does not compromise efficacy or safety when given in a flexible once-daily dosing regimen compared to insulin glargine once daily at the same time each day in type 2 diabetes. Diabetologia. 54. 8 indexed citations

Birkeland, K. I., Itamar Raz, S Gough, et al.. (2011). Insulin degludec in a flexible daily dosing regimen provides similar glycaemic control without increasing rates of hypoglycaemia compared to dosing the same time daily in type 2 diabetes. Diabetologia. 54. 6 indexed citations

Thorsby, Per Medbøe, et al.. (2005). An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study. Diabetic Medicine. 22(3). 316–322. 35 indexed citations

Thorsby, Per Medbøe, Jens Petter Berg, & K. I. Birkeland. (2005). Insulin gene variable number of tandem repeats is associated with increased fat mass during adolescence in non‐obese girls. Scandinavian Journal of Clinical and Laboratory Investigation. 65(2). 163–168. 8 indexed citations

Kilhovd, Bente, Ida Giardino, Peter A. Torjesen, et al.. (2003). Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism. 52(2). 163–167. 151 indexed citations

Karlsen, Trine, et al.. (2000). No difference in 3-day EPO response to 8, 12 or 16 hours/day of intermittant hypoxia. 251. 2 indexed citations

Kilhovd, Bente, Tore Julsrud Berg, K. I. Birkeland, Per Medbøe Thorsby, & K. F. Hanssen. (1999). Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.. Diabetes Care. 22(9). 1543–1548. 217 indexed citations

Birkeland, K. I.. (1998). Improving glycaemic control with current therapies. Diabetic Medicine. 15(S4). S13–S19. 2 indexed citations

10.

Thorsby, Per Medbøe, D E Undlien, Jens Petter Berg, E Thørsby, & K. I. Birkeland. (1998). [Diabetes mellitus--a complex interaction between heredity and environment].. PubMed. 118(16). 2519–24. 2 indexed citations

11.

Torjesen, Peter A., K. I. Birkeland, Sigmund A. Anderssen, et al.. (1997). Lifestyle Changes May Reverse Development of the Insulin Resistance Syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care. 20(1). 26–31. 165 indexed citations

12.

Hjeltnes, Nils, A. Aksnes, K. I. Birkeland, et al.. (1997). Improved body composition after 8 wk of electrically stimulated leg cycling in tetraplegic patients. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 273(3). R1072–R1079. 109 indexed citations

13.

Birkeland, K. I., et al.. (1996). NIDDM: a rapid progressive disease Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment. Diabetologia. 39(12). 1629–1633. 24 indexed citations

14.

Birkeland, K. I., Kristian F. Hanssen, Einar Stranden, Jan A. Falch, & Stein Vaaler. (1995). Insulin-Mediated Increase in Calf Blood Flow is Not Related to Blood Pressure Levels in Patients with Type 2 Diabetes Mellitus. Blood Pressure. 4(2). 80–84. 1 indexed citations

15.

Birkeland, K. I., et al.. (1995). BONE MASS IN NONINSULIN - DEPENDENT DIABETES MELLITUS. 55(3). 257–262. 7 indexed citations

16.

Birkeland, K. I., Kristian F. Hanssen, Petter Urdal, K. Berg, & Stein Vaaler. (1994). A long‐term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes. Journal of Internal Medicine. 236(3). 305–313. 19 indexed citations

17.

Birkeland, K. I.. (1993). Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism. 76(2). 275–278. 45 indexed citations

18.

Gullestad, Lars, et al.. (1992). Oral versus intravenous magnesium supplementation in patients with magnesium deficiency.. PubMed. 10(1). 11–6. 7 indexed citations

19.

Gullestad, Lars, K. I. Birkeland, Gudmund Nordby, Signe Holm Larsen, & John Kjekshus. (1991). Effects of selective beta 2‐adrenoceptor blockade on serum potassium and exercise performance in normal men.. British Journal of Clinical Pharmacology. 32(2). 201–207. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact